SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is gaining attention due to recent advancements in its pipeline, including significant progress in tecarfarin manufacturing and a collaboration with Abbott for its pivotal Phase 3 trial targeting LVAD patients. While some investors are optimistic about its potential in the anticoagulation market, community sentiment also highlights concerns around the company's cash position, recent offerings, and the notable presence of bot activity amplifying its trend.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth (USAR) is generating significant buzz following reports of a substantial planned investment from the US government, which includes an equity stake aimed at strengthening the domestic rare earth supply chain. This is further amplified by news of an upcoming rare earth metals and alloys production facility in France, bolstered by government support. The community is actively discussing the potential for a massive stock surge and a short squeeze, reflecting strong sentiment around the company's strategic importance in securing critical mineral resources.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC the metals company Inc. is trending after recent regulatory updates from NOAA allowed its US subsidiary to submit a consolidated application for an expanded deep-sea exploration and commercial recovery permit, streamlining the path to critical mineral production. The community is highly bullish, anticipating rapid permit approval and significant government backing due to national security implications and the urgent need for domestic supply of EV and low-carbon energy metals, with discussions frequently highlighting substantial upside and a potential short squeeze.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is trending following its mainnet migration to an EVM-compatible L2 on Arbitrum Orbit, positioning $JASMY as a custom gas token for AI and Web3 applications. This significant development has sparked intense debate, with many community members highlighting its foundational utility and regulatory backing in Japan as catalysts for a potential surge, while skeptics point to historical volatility and recent price action as typical 'pump and dump' behavior.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as intense debate erupts over a recent fatal shooting involving federal agents in Minneapolis. Community members are sharply divided, with some condemning the incident as an unjustified act against a citizen and others defending the agents' response to alleged interference with federal operations. This contentious event fuels broader discussions about federal authority and political polarization, potentially impacting ongoing government funding debates.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

DOG CRYPTO is trending amidst strong community excitement, primarily driven by rumors of a Coinbase listing and increasing institutional interest, with C2 Blockchain notably expanding its holdings. Enthusiasts are actively promoting it as the leading Bitcoin-native memecoin, emphasizing its fixed supply and decentralized nature as superior to other meme tokens and expressing high conviction for its long-term growth and potential to outperform.

Ethereum Classic

Ethereum Classic ($ETC) is trending with a mix of frustration over its lagging performance and fervent hope for an "alt season" rally. The community is actively debating its intrinsic value as a truly decentralized Proof-of-Work blockchain, with many long-term holders accumulating at current low levels. Optimism is fueled by anticipation of broader market catalysts like potential regulatory clarity and upcoming FED rate cuts, which could bring renewed institutional liquidity to the crypto sector.

The White Whale

WHITEWHALE is experiencing active community discussion around recent price volatility, with some attributing it to market manipulation and large-scale profit-taking. Despite this, a strong bullish sentiment persists, fueled by significant token burns, a substantial portion of supply locked long-term, and consistent growth in its holder base. The community largely views current dips as accumulation opportunities, reinforcing its belief in the token's long-term potential and legitimacy.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the following segments: Advanced Technology Solutions (ATS), and Connectivity and Cloud Solutions (CCS). The Advanced Technology Solutions (ATS) segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The Connectivity and Cloud Solutions (CCS) segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is trending due to recent market reports suggesting a potential shift in a major customer's assembly work, which many in the community are actively debating as a strategic play to acquire shares at a lower valuation. Despite this volatility, investors are highlighting the company's strong fundamentals and critical role in the expanding AI and data center infrastructure, with high anticipation for its upcoming earnings report to reaffirm its market leadership.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is actively discussed as a quantum computing leader following significant accumulation by institutional investors like BlackRock and its strategic advancement in government contracts. The company recently secured a $21.1 million Air Force project and joined the "Golden Dome" initiative, positioning itself as a full-stack quantum infrastructure provider, while its presence at CES 2026 highlights its commitment to commercial applications and ongoing community excitement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

J. Jefferson Smith Sells 10,200 Shares of Precision BioSciences (NASDAQ:DTIL) Stock

Precision BioSciences, Inc. (NASDAQ:DTIL - Get Free Report) insider J. Jefferson Smith sold 10,200 shares of the firm's stock in a transaction that occurred on Wednesday, January 21st. The shares...

Precision BioSciences (NASDAQ:DTIL) Insider J. Jefferson Smith Sells 10,200 Shares

Precision BioSciences, Inc. (NASDAQ:DTIL - Get Free Report) insider J. Jefferson Smith sold 10,200 shares of the business's stock in a transaction that occurred on Wednesday, January 21st. The shares...

Precision BioSciences (NASDAQ:DTIL) CFO Sells $61,308.39 in Stock

Precision BioSciences, Inc. (NASDAQ:DTIL - Get Free Report) CFO John Alexander Kelly sold 15,213 shares of the stock in a transaction dated Wednesday, January 21st. The stock was sold at an average...

Michael Amoroso Sells 34,799 Shares of Precision BioSciences (NASDAQ:DTIL) Stock

Precision BioSciences, Inc. (NASDAQ:DTIL - Get Free Report) CEO Michael Amoroso sold 34,799 shares of the company's stock in a transaction on Thursday, January 22nd. The stock was sold at an average...

Precision BioSciences (NASDAQ:DTIL) Trading Down 3.8% - Time to Sell?

Precision BioSciences (NASDAQ:DTIL) Shares Down 3.8% - Should You Sell...

Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS platform to develop in vivo gene editing therapies for high unmet need...

Short Interest in Precision BioSciences, Inc. (NASDAQ:DTIL) Expands By 27.4%

Precision BioSciences, Inc. (NASDAQ:DTIL - Get Free Report) was the recipient of a significant increase in short interest in the month of December. As of December 15th, there was short interest...

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS platform to develop in vivo gene editing therapies for diseases with high unmet...

Insider Buying: Precision BioSciences (NASDAQ:DTIL) Director Acquires $12,690.00 in Stock

Precision BioSciences, Inc. (NASDAQ:DTIL - Get Free Report) Director Stanley Frankel acquired 2,700 shares of the company's stock in a transaction that occurred on Tuesday, December 16th. The shares...

Precision BioSciences (NASDAQ:DTIL) Trading 4.9% Higher - Time to Buy?

Precision BioSciences (NASDAQ:DTIL) Stock Price Up 4.9% - Still a Buy...

Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's proprietary genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane on January 26, 2006 and is headquartered in Durham, NC.

Precision Biosciences Inc

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

DTIL
Precision Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest DTIL News

DTILPrecision Biosciences Inc